Cftr channel activator for use in the treatment and/or prevention of gluten sensitivity conditions
OwnerLuigi Maiuriinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to a CFTR channel activator, or a pharmaceutical composition thereof, for use in the treatment and/or prevention of conditions of gluten sensitivity, such as a) celiac disease (CD) and/or a celiac-associated condition and/or gluten-related diseases, selected from potential celiac disease, refractory celiac disease, type 1 diabetes, autoimmune thyroiditis, or (b) non-celiac gluten sensitivity (NCGS) or irritable bowel disease.
Claims9
A method of treating and/or preventing at least one intestinal and/or extra-intestinal condition of gluten sensitivity selected from celiac disease, non-celiac gluten sensitivity, potential celiac disease, refractory celiac disease, type diabetes, autoimmune thyroiditis and irritable bowel disease with a CFTR channel activator, said method comprising
- administering a pharmaceutically effective amount of said CFTR channel activator to a subject in need thereof.
Dependencies are inferred from the claim text.